Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison S Cleary

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Physiological Sciences : JPS|July 27, 2010
Skeletal muscle expression of bone morphogenetic protein-1 and tolloid-like-1 extracellular proteases in different fiber types and in response to unloading, food deprivation and differentiationDavid L Allen, Bradley J Greybeck, Bradley J Greyback, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 13, 2009
Calcineurin activates interleukin-6 transcription in mouse skeletal muscle in vivo and in C2C12 myotubes in vitroDavid L Allen, Jill J Uyenishi, Allison S Cleary, et al.
The American Journal of Surgical Pathology|July 3, 2025
The Clinicopathologic Features of Inflammatory Breast Carcinoma (IBC) With Lobular FeaturesS Emily Bachert, Allison M Onken, Allison S Cleary, et al.
Archives of Pathology & Laboratory Medicine|November 7, 2023
Clinicopathologic Features of 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 Breast Carcinoma (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio <2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥6.0)Diane Wilcock, Deepika Sirohi, Daniel Albertson, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 13, 2008
Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese miceDavid L Allen, Allison S Cleary, Kristin J Speaker, et al.
American Journal of Clinical Pathology|February 12, 2025
HER2 fluorescence in situ hybridization groups 2-4 breast cancers classified as positive after targeted recounts following equivocal (2+) immunohistochemistryDiane Wilcock, Deepika Sirohi, Joshua F Coleman, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 27, 2025
Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ HybridizationCameron Beech, Diane M Wilcock, Kristina H Moore, et al.
Archives of Pathology & Laboratory Medicine|March 15, 2023
Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast CancerDiane M Wilcock, Kristina H Moore, Leslie Rowe, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Physiological Sciences : JPS|July 27, 2010
Skeletal muscle expression of bone morphogenetic protein-1 and tolloid-like-1 extracellular proteases in different fiber types and in response to unloading, food deprivation and differentiationDavid L Allen, Bradley J Greybeck, Bradley J Greyback, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 13, 2009
Calcineurin activates interleukin-6 transcription in mouse skeletal muscle in vivo and in C2C12 myotubes in vitroDavid L Allen, Jill J Uyenishi, Allison S Cleary, et al.
The American Journal of Surgical Pathology|July 3, 2025
The Clinicopathologic Features of Inflammatory Breast Carcinoma (IBC) With Lobular FeaturesS Emily Bachert, Allison M Onken, Allison S Cleary, et al.
Archives of Pathology & Laboratory Medicine|November 7, 2023
Clinicopathologic Features of 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 Breast Carcinoma (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio <2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥6.0)Diane Wilcock, Deepika Sirohi, Daniel Albertson, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 13, 2008
Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese miceDavid L Allen, Allison S Cleary, Kristin J Speaker, et al.
American Journal of Clinical Pathology|February 12, 2025
HER2 fluorescence in situ hybridization groups 2-4 breast cancers classified as positive after targeted recounts following equivocal (2+) immunohistochemistryDiane Wilcock, Deepika Sirohi, Joshua F Coleman, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 27, 2025
Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ HybridizationCameron Beech, Diane M Wilcock, Kristina H Moore, et al.
Archives of Pathology & Laboratory Medicine|March 15, 2023
Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast CancerDiane M Wilcock, Kristina H Moore, Leslie Rowe, et al.
Pageof 2